Unitree's Humanoid Hype Draws Scrutiny as Valuation Nears $1 Billion
Unitree Robotics, the Hangzhou-based maker of dog-like and humanoid robots, has become the latest test case for a question hanging over China's tech sector: is this a breakthrough or a bandwagon? Open Magazine this week pegged the company's valuation at $904 million, inching toward the symbolic billion-dollar mark, while CNBC ran its own inquiry into whether the hardware inside Unitree's machines justifies the price investors are willing to pay for a piece of them.
Neither outlet disputes that Unitree makes real, working robots — the company has sold nimble quadrupeds for years and more recently unveiled bipedal humanoids that can walk, and in choreographed demonstrations, even perform backflips. What both are probing is the gap between that engineering and the narrative now attached to it: that humanoid robots are on the verge of leaving labs and entering factories, hospitals, and homes at scale. CNBC's framing is blunt — are investors buying Unitree's technology, or just buying a ticket into "humanoid," a label that has become shorthand for the next trillion-dollar category, regardless of what any particular machine can actually do today.
That distinction matters because valuations built on category excitement rather than deployed capability tend to move faster than the underlying technology can follow. Unitree's rise is happening inside a specifically Chinese pattern: state and provincial governments have poured subsidies and procurement promises into humanoid robotics as a strategic industry, echoing how China built dominance in solar panels and electric vehicles. Open Magazine's "gold rush" framing captures that dynamic — dozens of Chinese firms, not just Unitree, are racing to plant a flag in humanoids before the market consolidates, which tends to inflate valuations across the board even for companies with genuinely differentiated products.
For the robotics industry more broadly, the stakes of this scrutiny are practical. If capital keeps flowing to any company that can put two legs on a chassis and call it humanoid, the sector risks a shakeout later that punishes credible engineering along with the hype-driven froth — something Boston Dynamics and other Western robotics veterans have watched happen before in narrower booms. If, instead, firms like Unitree can convert flashy demo videos into robots that actually do useful, repeatable work in warehouses or eldercare or manufacturing, the current enthusiasm could look, in hindsight, like early recognition rather than mania.
For now, the honest answer from both CNBC and Open Magazine is that nobody knows yet which story this is. What's clear is that Unitree's approach to $1 billion has less to do with any single quarter's revenue than with a global bet that humanoid robots are the next platform shift — a bet that will eventually be judged not by valuation multiples but by whether the robots can hold a job.